Use Of Second-Generation Antipsychotics For Bipolar Disorder Rose From 12% To 51% Over 20 Years
The share of prescriptions for second-generation antipsychotics to treat bipolar disorder rose from 12.4% of prescriptions issued at outpatient visits in 1997 to 51.4% of visits in 2016. During this period, the number of outpatient visits for bipolar disorder rose by 127%, from about 467,000 visits occurring from 1997 through 2000; to about 1.06 million visits occurring from 2013 through 2016. During this period, the share of people prescribed medication to treat bipolar disorder who also received psychotherapy dropped from …
Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI). Specific PsychU programs may be supported by OPDC, OAPI and other committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsor or the sponsors of the specific PsychU program in which such opinions are expressed. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU's educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC and OAPI.